AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harris, W. S.
Right arrow Articles by Connor, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harris, W. S.
Right arrow Articles by Connor, W. E.
Agricola
Right arrow Articles by Harris, W. S.
Right arrow Articles by Connor, W. E.

American Journal of Clinical Nutrition, Vol 51, 399-406, Copyright © 1990 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Fish oils in hypertriglyceridemia: a dose-response study

WS Harris, DW Rothrock, A Fanning, SB Inkeles, SH Goodnight Jr, DR Illingworth and WE Connor
Division of Endocrinology, Metabolism and Clinical Nutrition, Oregon Health Sciences University, Portland.

The effects of three supplemental doses of fish oil on plasma lipids, lipoproteins, and bleeding times were studied in ten hypertriglyceridemic patients. After a 3-wk baseline period each patient was given 15, 25, or 40 mL fish oil/d (containing 4.5, 7.5, and 12 g n-3 fatty acids) for three successive 6-wk periods, each separated by a 4-wk period of no supplementation. Plasma cholesterol concentrations decreased from 7.40 mmol/L to 6.35, 6.55, and 6.40 mmol/L with increasing doses of fish oil (p less than 0.01 vs baseline for each). Plasma triglyceride concentrations decreased from 6.10 mmol/L to 2.90, 2.80, and 2.35 mmol/L (p less than 0.01 vs baseline for each). Low-density-lipoprotein cholesterol concentrations increased significantly (by 23% and 28%) with the two higher doses, respectively. Bleeding times increased only with the largest dose. The lowest dose was the most hypolipidemic per gram n-3 fatty acids.


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
Y. Park, P. G Jones, and W. S Harris
Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids
Am. J. Clinical Nutrition, July 1, 2004; 80(1): 45 - 50.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Park and W. S. Harris
Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance
J. Lipid Res., March 1, 2003; 44(3): 455 - 463.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
References
Circulation, December 17, 2002; 106(25): 3373 - 3421.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by The American Society for Nutrition